Fungal Meningitis Treatment Guidelines

Introduction to Fungal Meningitis Treatment

The American College of Physicians recommends initiating induction therapy with amphotericin B deoxycholate (0.7-1.0 mg/kg/day) plus flucytosine (100 mg/kg/day) for 2 weeks, followed by fluconazole consolidation and maintenance therapy for patients with cryptococcal meningitis 1
The Infectious Diseases Society of America suggests that the combination of amphotericin B plus flucytosine is superior to amphotericin B alone and represents the highest level of evidence (A-I) for HIV-infected patients 1

The standard regimen for cryptococcal meningitis is amphotericin B deoxycholate 0.7-1.0 mg/kg/day IV plus flucytosine 100 mg/kg/day orally for 2 weeks, with a strength of evidence of A-I 1, 2
For patients with renal impairment, liposomal amphotericin B (3-4 mg/kg/day) or ABLC (5 mg/kg/day) plus flucytosine is preferred, particularly in transplant recipients who often have baseline renal dysfunction and concurrent nephrotoxic medications 1, 2
When flucytosine is unavailable, amphotericin B alone for 4-6 weeks or amphotericin B plus high-dose fluconazole (400-800 mg daily) for 2 weeks can be used 1, 2
Fluconazole 400 mg daily for 8 weeks after completing induction therapy is recommended for consolidation therapy 1, 2
Fluconazole 200 mg daily for at least 1 year is recommended for maintenance therapy to prevent relapse 1

The Infectious Diseases Society of America recommends induction therapy with amphotericin B 0.7-1.0 mg/kg/day to complete 35 mg/kg total dose over 3-4 months for histoplasma meningitis 5, 6
Consolidation/maintenance therapy with fluconazole 800 mg daily for 9-12 months after completing amphotericin B is recommended to reduce relapse risk 5, 6

The Infectious Diseases Society of America suggests that the preferred regimen for candida meningitis is liposomal amphotericin B plus flucytosine for at least 2 weeks, with treatment duration ranging from 4-10 weeks depending on response 7, 4
High-dose fluconazole (400-800 mg daily) has been used as follow-up or long-term suppressive therapy 4, 7

Monitoring of flucytosine serum levels (target: 30-80 μg/mL or 40-60 mg/mL) and adjustment of dose based on renal function is recommended 4, 1
Serial lumbar punctures to document CSF sterilization are recommended 1
Monitoring of serum electrolytes and renal function for amphotericin B nephrotoxicity is recommended 3
Elevated intracranial pressure should be aggressively managed, with measurement of opening pressure at baseline lumbar puncture and therapeutic lumbar punctures to reduce pressure by 50% or to ≤20 cm H₂O 2

HIV-infected patients should delay antiretroviral therapy initiation for 2-10 weeks after starting antifungal treatment to reduce risk of immune reconstitution inflammatory syndrome (IRIS) 1
Pediatric patients should receive amphotericin B 0.7-1.0 mg/kg/day plus flucytosine for induction, followed by fluconazole 12 mg/kg on first day, then 6 mg/kg daily 1
Immunocompetent patients may not require prolonged maintenance therapy if immunosuppression can be reduced 3